Literature DB >> 15019858

The diabetes epidemic: a national and global crisis.

Robert O Bonow1, Mihai Gheorghiade.   

Abstract

Diabetes mellitus is a serious problem that will soon reach epidemic proportions in the United States and throughout the world. The incidence of this condition will skyrocket in the next quarter century as demographic changes increase the size of highly susceptible populations (e.g., the elderly and Hispanic communities) and sociocultural developments create a more sedentary populace as well as expose people in developing nations to new risk factors for this disease. Along with substantial direct morbidity and mortality, diabetes is independently associated with the incidence and severity of a variety of cardiovascular illnesses. Individuals with diabetes are substantially more likely than their nondiabetic counterparts to suffer stroke, myocardial infarction, or heart failure, with a worse prognosis following any of these conditions. Many factors may be relevant to this association, but recent studies have elucidated a major role for the metabolic syndrome, which has been shown to be predictive of both diabetes and cardiovascular disease. Consequently, early intervention to control blood glucose levels and other risk factors may mitigate the severity of these conditions, possibly even before the disease begins.

Entities:  

Mesh:

Year:  2004        PMID: 15019858     DOI: 10.1016/j.amjmed.2003.10.014

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

1.  An information-motivation-behavioral skills analysis of diet and exercise behavior in Puerto Ricans with diabetes.

Authors:  Chandra Y Osborn; K Rivet Amico; William A Fisher; Leonard E Egede; Jeffrey D Fisher
Journal:  J Health Psychol       Date:  2010-05-07

2.  Comparison of known food weights with image-based portion-size automated estimation and adolescents' self-reported portion size.

Authors:  Christina D Lee; Junghoon Chae; TusaRebecca E Schap; Deborah A Kerr; Edward J Delp; David S Ebert; Carol J Boushey
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  Traditional Chinese medicine formula Qing Huo Yi Hao as superoxide anion scavenger in high glucose-treated endothelial cells.

Authors:  Qiong Xu; Bin Zhang; Xiao-mu Li; Xin Gao
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

4.  Novel interactive cell-phone technology for health enhancement.

Authors:  David L Katz; Bjorn Nordwall
Journal:  J Diabetes Sci Technol       Date:  2008-01

Review 5.  Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 6.  Are thiazolidinediones good or bad for the heart?

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

7.  The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

Authors:  Sameer Bansilal; Michael E Farkouh; Whady Hueb; May Ogdie; George Dangas; Alexandra J Lansky; David J Cohen; Elizabeth A Magnuson; Krishnan Ramanathan; Jean-Francois Tanguay; Victoria Muratov; Lynn A Sleeper; Michael Domanski; Michel E Bertrand; Valentin Fuster
Journal:  Am Heart J       Date:  2012-10       Impact factor: 4.749

Review 8.  The changing disease-scape in the third epidemiological transition.

Authors:  Kristin Harper; George Armelagos
Journal:  Int J Environ Res Public Health       Date:  2010-02-24       Impact factor: 3.390

9.  The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse.

Authors:  Rashmi Kumari; Lisa B Willing; Shyama D Patel; J Kyle Krady; William J Zavadoski; E Michael Gibbs; Susan J Vannucci; Ian A Simpson
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

10.  Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.

Authors:  Gary T C Ko; Wing-Yee So; Peter C Tong; Wing-Bun Chan; Xilin Yang; Ronald C Ma; Alice P Kong; Risa Ozaki; Chun-Yip Yeung; Chun-Chung Chow; Juliana C Chan
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.